In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin

Molecular and Cellular Neurosciences

Volumn 15, Issue 2, 2000, Pages 199-214

  Rosenblad, Carl ^a   Grønborg, Mette ^b   Hansen, Claus ^c   Blom, Nikolaj ^d   Meyer, Morten ^e   Johansen, Jens ^b   Dagø, Lone ^b   Kirik, Deniz ^a   Patel, Umesh A ^f   Lundberg, Cecilia ^a   Trono, Didier ^g   Björklund, Anders ^a   Johansen, Teit E ^b  

^a LUND UNIVERSITY   (Sweden)

^b NEUROSEARCH A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f ProMetic Life Sciences Inc   (Canada)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIN; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; DRUG POTENCY; GENE TRANSFER; HUMAN; LENTIVIRINAE; MOLECULAR CLONING; MOUSE; NERVE GROWTH; NERVE INJURY; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALIA; LENTIVIRUS;

EID: 0033978389     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1999.0817     Document Type: Article

References (55)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:1946;239-247.
2. Akerud P., Alberch J., Eketjall S., Wagner J., Arenas E. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J. Neurochem. 73:1999;70-78.
3. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
4. Baloh R. H., Tansey M. G., Golden J. P., Creedon D. J., Heuckeroth R. O., Keck C. L., Zimonjic D. B., Popescu N. C., Johnson E. M., Milbrandt J. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron. 18:1997;793-802.
5. Baloh R. H., Tansey M. G., Lampe P. A., Fahrner T. J., Enomoto H., Simburger K. S., Leitner M. L., Araki T., Johnson E. M. Jr., Milbrandt J. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron. 21:1998;1291-1302.
6. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult rat. Nature. 373:1995;339-341.
7. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J. J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA. 94:1997;8818-8823.
8. Blomer U., Naldini L., Kafri T., Trono D., Verma I. M., Gage F. H. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:1997;6641-6649.
9. Cacalano G., Farinas I., Wang L.-C., Hagler K., Forgie A., Moore M., Armanini M., Phillips H., Ryan A. M., Reichardt L. F., Hynes M., Davies A., Rosenthal A. GFR-alfa1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron. 21:1998;1-20.
10. Chang J.-W., Wachtel S. R., Young D., Kang U.-J. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of parkinson's disease: Studies on medial forebrain bundle and striatal lesions. Neuroscience. 88:1999;617-628.
11. Choi-Lundberg D. L., Lin Q., Chang Y. N., Chiang Y. L., Hay C. M., Mohajeri H., Davidson B. L., Bohn M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy [see comments]. Science. 275:1997;838-841.
12. Choi-Lundberg D. L., Lin Q., Schallert T., Crippens D., Davidson B. L., Chang Y. N., Chiang Y. L., Qian J., Bardwaj L., Bohn M. C. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp. Neurol. 154:1998;261-275.
13. Crews L. L., Wigston D. J. The dependence of motorneurons on their target muscle during postnatal development of the mouse. J. Neurosci. 10:1990;1643-1653.
14. Deglon N., Tseng J. L., Bensadoun J.-C., Zufferey R., Trono D., Aebischer P. Protection of dopaminergic neurons from axotomy-induced degeneration with a GDNF-expressing lentiviral vector. Soc. Neurosci. Abstract. 400.5. 1998.
15. Golden J. P., Baloh R. H., Kotzbauer P. T., Lampe P. A., Osborne P. A., Milbrandt J., Johnson E. M. Jr. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J. Comp. Neurol. 398:1998;139-150.
16. Hoffer B. J., Hoffman A., Bowencamp K., Huettl P., Hudson J., Martin D., Lin L.-F. H., Gerhardt G. Glial cell line-derived neurotrophic factor reverses toxin induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:1994;107-111.
17. Horger B., Nishimura M., Armanini M., Wang L.-C., Poulsen K., Rosenblad C., Kirik D., Moffat B., Simmons L., Johnson E., Milbrandt J., Rosenthal A., Bjorklund Anders, Vandlen R., Hynes M., Phillips H. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18:1998;4929-4937.
18. Jenkins R., O'Shea R., Thomas K. L., Hunt S. P. c-jun expression in substantia nigra neurons following striatal 6-hydroxydopamine lesions in the rat. Neuroscience. 53:1993;447-455.
19. Jing S., Wen D., Yu Y., Holst P. L., Lou Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.-C., Hu S., Altrock B. W., Fox G. M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFRa, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
20. Johansen T. E., Scholler M. S., Tolstoy S., Schwartz T. W. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett. 267:1990;289-294.
21. Karlsson J., Emgard M., Rosenblad C., Brundin P. Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons. Brain Res. 805:1998;155-168.
22. Kearns C. M., Cass W. A., Smoot K., Kryscio R., Gash D. M. GDNF protection against 6-OHDA: Time dependence and requirement for protein synthesis. J. Neurosci. 17:1997;7111-7118.
23. Kirik D., Rosenblad C., Björklund A. Characterization of behavioural and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152:1998;259-277.
24. Kotzbauer P. T., Lampe P. A., Heuckeroth R. O., Golden J. P., Creedon D. J., Johnson E. M. J., Milbrandt J. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature. 384:1996;467-470.
25. Lee C. S., Sauer H., Björklund A. Dopaminergic neuronal degeneration and motor impairments following lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience. 72:1996;641-653.
26. Lin L.-F. H., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
27. Lu X., Hagg T. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats. J. Comp. Neurol. 388:1997;484-494.
28. Mandel R. J., Spratt S. K., Snyder R. O., Leff S. E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA. 94:1997;14083-14088.
29. Matsushita N., Fujita Y., Tanaka M., Nagatsu T., Kiuchi K. Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF. Gene. 203:1997;149-157.
30. McAllister A. K., Lo D. C., Katz L. C. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron. 15:1995;791-803.
31. Milbrandt J., de Sauvage F. J., Fahrner T. J., Baloh R. H., Leitner M. L., Tansey M. G., Lampe P. A., Heuckeroth R. O., Kotzbauer P. T., Simburger K. S., Golden J. P., Davies J. A., Vejsada R., Kato A. C., Hynes M., Sherman D., Nishimura M., Wang L. C., Vandlen R., Moffat B., Klein R. D., Poulsen K., Gray C., Garces A., Johnson E. M. Jr. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 20:1998;245-253.
32. Minichiello L., Casagranda F., Tatche R. S., Stucky C. L., Postigo A., Lewin G. R., Davies A. M., Klein R. Point mutation in trkB causes loss of NT4-dependent neurons without major effects on diverse BDNF responses. Neuron. 21:1998;335-345.
33. Nakayama K. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327:1997;625-635.
34. Naldini L., Blomer U., Gage F. H., Trono D., Verma I. M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA. 93:1996a;11382-11388.
35. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see Comments]. Science. 272:1996b;263-267.
36. Naveilhan P., Baudet C., Mikaels A., Shen L., Westphal H., Ernfors P. Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptor. Proc. Natl. Acad. Sci. USA. 95:1998;1295-1300.
37. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
38. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togaski D. M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-647.
39. Renfranz P. J., Cunningham M. G., McKay R. D. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell. 66:1991;713-729.
40. Rosenblad C., Kirik D., Devaux B., Moffat B., Phillips H. S., Björklund A. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur. J. Neurosci. 11:1999;1554-1566.
41. Rosenblad C., Martinez-Serrano A., Björklund A. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigraostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience. 82:1998;129-137.
42. Sauer H., Oertel W. H. Progressive degeneration of nigrostriatal dopamine neurons following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience. 59:1994;401-415.
43. Sauer H., Rosenblad C., Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor-β prevents degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
44. Shults C. W., Kimber T., Martin D. Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. Neuroreport. 7:1996;627-631.
45. Sloot W. N., Gramsbergen J. B. Detection of salicylate and its hydroxylated adducts 2,3- and 2,5-dihydroxybenzoic acids as possible indices for in vivo hydroxyl radical formation in combination with catechol- and indoleamines and their metabolites in cerebrospinal fluid and brain tissue. J. Neurosci. Methods. 60:1995;141-149.
46. Stoppini L., Buchs P. A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:1991;173-182.
47. Sullivan A. M., Opacka-Juffrey J., Blunt S. B. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Eur. J. Neurosci. 10:1998;57-63.
48. Tomac A., Lindqvist E., Lin L.-F. H., Ögren S. O., Young D., Hoffer B. J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
49. Tomac A., Widenfalk J., Lin L.-F., Kohno T., Ebendal T., Hoffer B. J., Olson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA. 92:1995;8274-8278.
50. Treanor J. J. S., Goodman L., de Sauvage F., Stone D. M., Poulsen K. T., Beck C. D., Gray C., Armanini M. P., Pollock R. A., Moore M. W., Buj-Bello A., Davies A. M., Asai N., Takahashi M., Vandlen R., Henderson C. E., Rosenthal A. Characterization of a multicompetent receptor for GDNF. Nature. 382:1996;80-83.
51. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
52. Widenfalk J., Nosrat C., Tomac A., Westphal H., Hoffer B., Olson L. Neurturin and glial cell line-derived neurotrophic factor receptor-β (GDNFRβ), novel proteins related to GDNF and GDNFR-a with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J. Neurosci. 17:1997;8506-8519.
53. Widenfalk J., Tomac A., Lindqvist E., Hoffer B., Olson L. GFRalpha-3, a protein related to GFRalpha-1, is expressed in developing peripheral neurons and ensheathing cells. Eur. J. Neurosci. 10:1998;1508-1517.
54. Winkler C., Sauer H., Lee C. S., Björklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 16:1996;7206-7215.
55. Zufferey R., Donello J. E., Trono D., Hope T. J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:1999;2886-2892.